Adhansia XR™ (methylphenidate) – New drug approval
February 27, 2019 - The FDA approved Purdue Pharma’s Adhansia XR (methylphenidate) extended-release capsules, for the treatment of attention deficit hyperactivity disorder (ADHD) in patients 6 years and older.
Download PDF
